Breakthrough in Diabetes Therapy … Just Around the Corner?

William A. Rudert, Massimo Trucco

Read More

The Role of the CXCL10/CXCR3 System in Type 1 Diabetes

Akira Shimada , Yoichi Oikawa , Yoshifumi Yamada, Yoshiaki Okubo ,Shosaku Narumi

Read More

Histopathology of Type 1 Diabetes: Old Paradigms and New Insights

Ken T. Coppieters, Matthias G. von Herrath

Read More

Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations

Jenny M. Phillips, Nicole M. Parish, Tim Raine, Chris Bland, Yvonne Sawyer, Hugo De La Peña, Anne Cooke

Read More

Allelic Variation of Ets1 Does Not Contribute to NK and NKT Cell Deficiencies in Type 1 Diabetes Susceptible NOD Mice

Margaret A. Jordan , Julie M. Fletcher, Alan G. Baxter ,Lynn D. Poulton

Read More

Comparison of Fasting Glucose with Post-Load Glucose Values and Glycated Hemoglobin for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study

Mohsen Janghorbani, Masoud Amini

Read More

Prevalence of Diabetic Retinopathy and Cataract in Adult Patients With Type 1 And Type 2 Diabetes in Russia

Ivan Dedov, Oxana Maslova, Yurii Suntsov, Lubov Bolotskaia, Tamara Milenkaia, Lena Besmertnaia

Read More

Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations

Arie Gruzman, Gali Babai, Shlomo Sasson

Read More